Showing 581-590 of 3001 results for "".
Epilepsy: In-Focus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/one-size-does-not-fit-all/30427/How to Tailor Individualized Treatment Regimens in Epilepsy CareAlzheimer's: Bad Blood Runs Deep
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/alzheimers-bad-blood-runs-deep/30734/A new study says damaged blood vessels loaded with amyloid worsen cognitive impairment in Alzheimer's disease. What are the implications?Practice Management Deadlines Loom for Clinical Neurologists
https://practicalneurology.com/columns/practice-management/practice-management-deadlines-loom-for-clinical-neurologists/30811/Learn what you need to do to comply with new initiatives and protect your practice from fines and penalties.FDA Filing for Cannabidiol, Data on Diet and Exercise and Brain Aging and Memory, Boston Scientific Indication for DBS
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/fda-filing-for-cannabidiol-data-on-diet-and-excercise-and-brain-aging-and-memory-boston-scientific-indication-for-dbs/30285/Evidence Lost? Epilepsy Surgery Not as Common as It Should Be
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/evidence-lost-epilepsy-surgery-not-as-common-as-it-should-be/30768/Doctors stress the importance of evidence-based medicine. So why aren't more patients having epilepsy surgery?Neurologists' Experiences with EHRs: The Texas Perspective
https://practicalneurology.com/columns/practice-management/neurologists-experiences-with-ehrs-the-texas-perspective/30779/The Texas Neurological Society surveyed its membership about their experiences with EHRs. Results show generally moderate to low satisfaction.Genetically Targeted Therapies for Inherited Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetically-targeted-therapies-for-inherited-neuromuscular-disorders/31816/Targeted genetic therapies for neuromuscular disorders have ushered in a new era with still unresolved clinical, ethical, and economic questions to address.Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis/31814/More treatments for myasthenia gravis are on the way.Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.